Clinical guidance on switching protocols will emerge post-approval
PubMed abstract Structural innovation for hypoglycemia prevention in high-risk patients with type 2 diabetes: Design and implementation of a pragmatic, randomized, quality improvement trial Authors: Chen, Minnie W;Parker, Melissa M;Karter, Andrew J;Grant, Richard W;Gilliam, Lisa K Contemp Clin Trials
Unlike a permanent cure for obesity or diabetes, GLP-1RAs provide benefits that diminish rapidly once treatment ends
[6] What Are Your Options
SURMOUNT-5 Results (72 weeks, NEJM May 2025) At their then-maximum doses (tirzepatide 1015mg vs semaglutide 1.72.4mg), Mounjaro delivered 47% more relative weight loss
These are very critical nutrients that, when depleted, will disrupt methylation, DNA synthesis, and neurological function